Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Psyence Biomedical Ltd. - Ordinary Shares (NQ:PBM)

4.950 +0.410 (+9.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Psyence Biomedical Ltd. - Ordinary Shares

< Previous 1 2 3 4 Next >
Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia
 
Via Benzinga
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart... 
Via Benzinga
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) rose sharply in today’s pre-market trading after the company announced its 2024 strategic layout with plans to enter the real estate stock asset... 
Via Benzinga
Why Is Psyence Biomedical (PBM) Stock Up 90% Today?
With Psyence Biomedical moving into a Phase 2B trial, the credibility boost for its psychedelics-based drug lifted PBM stock. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are a great way to start the week as we check out all of the biggest trades happening on Monday morning! 
Via InvestorPlace
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
What's Going On With Psyence Biomedical Stock?
On Wednesday, Psyence Biomedical announced the approval for its Phase IIb study to examine the use of psilocybin as a treatment for Adjustment Disorder due to a recent cancer diagnosis in the... 
Via Benzinga
Nasdaq Gains Over 50 Points; US Economy Adds 275,000 Jobs In February
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Friday. Following the market opening Friday, the Dow traded up 0.04% to 38,805.52 while the NASDAQ rose 0.41%... 
Via Benzinga
Topics Economy Stocks
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Why CrowdStrike Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Shares of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) shares surged 24.4% to $370.27 in pre-market trading after the company reported better-than-expected fourth-quarter earnings and revenues and issued... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting Thursday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning! 
Via InvestorPlace
Why Fortinet Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Shares of Fortinet, Inc. (NASDAQ: FTNT) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued guidance. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Tuesday morning and we've got all of the coverage traders need to know about them today! 
Via InvestorPlace
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.